Prosthetic Joint Infection (PJI) Market to Observe Stunning Growth During the Forecast Period (2022-2032), Evaluates DelveInsight

As per DelveInsight, the Prosthetic Joint Infection Market size was found to be USD 57.73 million in 2017, which is expected to grow by 2032. The Prosthetic Joint Infection Market is anticipated to grow owing to the increasing number of cases of Joint Arthroplasties, the favorable environment for new anti-infective modalities, and the expected launch of emerging therapies. Currently, some of the key players, such as Arrevus, TenNor Therapeutics, Peptilogics, and others, are actively working in the Prosthetic Joint Infection Market to improve the treatment dynamics.

DelveInsight's "Prosthetic Joint Infection Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Prosthetic Joint Infection Market Size and Share in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).

The Prosthetic Joint Infection market report covers emerging drugs, treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Prosthetic Joint Infection: An Overview
Prosthetic joint infection (PJI), or periprosthetic infection, is defined as an infection involving the joint prosthesis and adjacent tissue. The clinical manifestations of Prosthetic Joint Infection vary depending upon the organism's virulence, the mode of initiation of infection, the host immune response, the soft tissue structure surrounding the joint, and the joint involved.

The diagnosis of Prosthetic Joint Infection is based upon a combination of clinical findings, laboratory results from peripheral blood and synovial fluid, microbiological data, histological evaluation of periprosthetic tissue, intraoperative inspection, and radiographic results. Treatment for Prosthetic Joint Infection involves surgical intervention and medical therapy with an aim to eradicate the infection, restore the pain-free function of the infected joint, and minimize PJI-related morbidity and mortality for the patient.

Prosthetic Joint Infection Market Key Facts
• Total incident cases of Prosthetic joint infection in 7MM countries were estimated to be 58,000+ in 2017.
• As per the estimates, the United States has the highest incident population of Prosthetic joint infection, with 35,000+ cases in 2017.
• Among the European countries, Germany had the highest population of Prosthetic Joint infections, with 10,000+ cases, followed by the UK in 2017.
• In the study conducted by Anyaehie et al. (2020) to identify the definition, epidemiology, risk factors, pathology, classification, diagnosis, treatment, and prevention of Prosthetic Joint Infection. Prosthetic Joint Infection was observed to be a devastating complication of joint arthroplasty, with an average 1-year incidence of 0.25%-1.0% for primary total hip replacement (THR) and 0.4%-2% for primary total knee replacement (TKR). The incidence rate of infection in revision surgery was even higher, with an estimated rate of 3.2%-5.6% for both hips and knees.

Prosthetic Joint Infection Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Prosthetic Joint Infection market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Prosthetic Joint Infection market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MOA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Discover How Prosthetic Joint Infection Market will Grow by 2032:
https://www.delveinsight.com/report-store/prosthetic-joint-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Prosthetic Joint Infection Epidemiology
The epidemiology section covers detailed insights into the historical and current Prosthetic Joint Infection patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032.

The Report Covers the Prosthetic Joint Infection Epidemiology Segmented as -
• Total cases of Arthroplasty (2019-2032)
• Causative Microorganism-specific cases of Prosthetic joint infection (2019-2032)
• Total incident cases of Prosthetic joint infection (2019-2032)
• Gender-specific cases of Prosthetic joint infection (2019-2032)

Get Key Insights Into the Evolving Prosthetic Joint Infection Epidemiology Trends:
https://www.delveinsight.com/report-store/prosthetic-joint-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Prosthetic Joint Infection Drugs Uptake and Pipeline Development Activities
The drugs' uptake section focuses on the rate of uptake of the potential drugs recently launched in the Prosthetic Joint Infection market or expected to be launched during the study period. The analysis covers Prosthetic Joint Infection market uptake by drugs, patient uptake by therapies, and sales of each drug.

The report's drugs uptake section helps in understanding the drugs with the most rapid uptake and reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Prosthetic Joint Infection Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Explore More About Ongoing Pipeline Development Activities:
https://www.delveinsight.com/sample-request/prosthetic-joint-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Prosthetic Joint Infection Therapeutics Assessment
Novel strategies have shown promising results in the treatment of Prosthetic Joint infections; however, most of these therapies are still in preclinical development. Further, research and development of new diagnostic methods with more accuracy, simplicity, and convenience are required to fulfill the current unmet need.

The Leading Companies in the Prosthetic Joint Infection Therapeutics Market Include:
• Armata Pharmaceuticals
• Arrevus
• Contrafect
• Joint Purification Systems
• Osteal Therapeutics
• Peptilogics
• TenNor Therapeutics
And Many Others

Prosthetic Joint Infections Emerging and Marketed Drugs Covered in the Report Include:
• TNP 2092: TenNor Therapeutics
• PLG0206: Peptilogics
• Sodium Fusidate: Arrevus
• Exebacase: ContraFect
• Vancomycin hydrochloride and tobramycin sulfate: Joint Purification Systems
And Many Others

Learn More About the Emerging Therapies & Key Companies in the Prosthetic Joint Infection Therapeutics Market:
https://www.delveinsight.com/sample-request/prosthetic-joint-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Prosthetic Joint Infection Competitive Intelligence Analysis
4. Prosthetic Joint Infection Market Overview at a Glance
5. Prosthetic Joint Infection Background and Overview
6. Prosthetic Joint Infection Patient Journey
7. Prosthetic Joint Infection Epidemiology and Patient Population
8. Prosthetic Joint Infection Treatment Algorithm, Current Treatment, and Medical Practices
9. Prosthetic Joint Infection Unmet Needs
10. Key Endpoints of Prosthetic Joint Infection Treatment
11. Prosthetic Joint Infection Marketed Products
12. Prosthetic Joint Infection Emerging Therapies
13. Prosthetic Joint Infection Seven Major Market Analysis
14. Attribute Analysis
15. Prosthetic Joint Infection Market Outlook (7 major markets)
16. Prosthetic Joint Infection Access and Reimbursement Overview
17. KOL Views on the Prosthetic Joint Infection Market.
18. Prosthetic Joint Infection Market Drivers
19. Prosthetic Joint Infection Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.

Download the Sample PDF to Get Detailed Insights About the Report's Offerings:
https://www.delveinsight.com/sample-request/prosthetic-joint-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.